Significance of Timer Medication Box and Daily Blood Pressure Profile in Pharmacterapy of Hypertension after Covid-19 Transfer

Authors

  • Islombek Bahtiyor O'gli Bektashov Lecturer, Andijan State Medical Institute, Uzbekistan
  • Irodakhon Mahkambaevna Tashtemirova Lecturer, Andijan State Medical Institute, Uzbekistan
  • Qodirova Gulchehra Ibrohimovna Lecturer, Andijan State Medical Institute, Uzbekistan

Keywords:

arterial hypertension, COVID-19, pharmacotherapy, timer drug box

Abstract

Since December 2019, when the first case of SARS was detected in China, the first data on the peculiarities of the course of infection in patients with various diseases have appeared.

In particular, there have been reports of a greater susceptibility to infection of people with cardiovascular diseases and, in particular, with arterial hypertension, and a significantly higher risk of developing adverse outcomes in this group of patients. We present an analysis of the currently available publications concerning coronavirus infection in people with arterial hypertension.

The article describes the risks and approaches to the management of such patients against the background of coronavirus infection in patients with hypertension, including those associated with antihypertensive therapy (including blockers of the renin-angiotensin-aldosterone system), as well as the role of the timer box in its daily monitoring profile when blood pressure increases.

Downloads

Published

2022-11-10

How to Cite

Bektashov, I. B. O. ., Tashtemirova, I. M. ., & Ibrohimovna, Q. G. . (2022). Significance of Timer Medication Box and Daily Blood Pressure Profile in Pharmacterapy of Hypertension after Covid-19 Transfer. Vital Annex: International Journal of Novel Research in Advanced Sciences, 1(5), 10–13. Retrieved from https://innosci.org/IJNRAS/article/view/423

Issue

Vol. 1 No. 5 (2022): November 2022

Section

Articles